Navigating Conflicts, Motivations, and Rewards of Industry-Sponsored Research

Medical research funding has evolved over the past few decades, with private sources of funding outpacing government funding by a wide margin. Additionally, commercially funded early-stage research has declined in favor of medical devices, bioengineered drugs, and later-stage clinical trials.

Industry-sponsored research has traditionally been considered contextually different from government-funded research by academic medical centers due to different or nonexistent incentive structures within academia for industry-sponsored trialists, as well as perceptions of conflict of interest. Industry-sponsored studies are typically more restrictive and involve research questions that are predetermined and in line with the commercial entity’s interests rather than the trialist’s.

However, many clinical researchers find industry-sponsored research to be feasible and rewarding. Clinician-scientists can often find privately funded trials that align with their interests and can benefit from participating in multiple trials surrounding a common theme.

This unique webcast will feature stakeholders from academia and industry who will share their perspectives and explore issues surrounding industry-sponsored research.

Wednesday, September 17, 2025
12:45 p.m. – 1:45 p.m. Central Time

Register Now 

Please log in or create an account before clicking Register Now.
To log in or create an account, click here or navigate to the menu bar at the top of the page and select Log In then Sign In/Sign Up.

Can't make the live event? Register anyway and receive a link to the recording.

Learning Objectives

• Evaluate researchers’ advantages and challenges of pursuing industry funding
• Apply strategic principles to the development of funding proposals
• Identify key elements of successful industry-funded research proposals